跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
海芮思 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Idursulfase beta Injection
Approved
生物制品
Idursulfase beta Injection
绿十字
🇨🇳 National Medical Products Administration
Approval Date
Sep 2, 2020
Approval ID
81u8kAjDAYF
Company
绿十字
Type
生物制品
Approval Details
Approval Id
81u8kAjDAYF
Approval Number
国药准字SJ20200022
Generic Name
艾度硫酸酯酶β注射液
Generic Name En
Idursulfase beta Injection
Trade Name
海芮思
Drug Type
生物制品
Dosage Form
注射剂
Strength
6mg(3mL)/瓶
Reg Date
2020-09-02
Expired Date
2025-09-01
Company Name
绿十字
Company Address
586 Gwahaksaneop 2-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do
Production Company Name
GREEN CROSS CORPORATION
Production Company Address
586 Gwahaksaneop 2-ro, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do
Production Company Detail Path
/organization/green-cross-corporation
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 2, 2020
Approval ID
81u8kAjDAYF
Type
生物制品
Back to NMPA Approvals